We are proud to announce that Great Hill Managing Directors Mark Taber and Rafael Cofiño have been named on GrowthCap’s 2023 List of Top 25 Healthcare Investors. Awardee selections were based on each nominee's breadth of investing experience, professional milestones achieved and feedback from colleagues and portfolio company CEOs.

"Our focus at Great Hill has been to work with companies seeking to lower overall healthcare costs, while improving access to quality care and enhancing the patient experience,” said Mark. “We have been fortunate to partner with some of the most innovative teams pursuing these goals over the past two decades. We are excited about the opportunities today as we have ever been."

“At Great Hill, we are fortunate to partner with high growth healthcare companies whose core mission is to help expand access to care at a lower cost with better outcomes for as many individuals as possible,” said Rafael. “While we are extremely proud of the impact our partners are having in the industry, we recognize there is still much to do. It is this sense of urgency that drives us to invest our time, experience and capital to support the visionary teams looking to improve the way healthcare is delivered, utilized and paid.”

Mark and Rafael’s collective current and prior healthcare investments at Great Hill include Clearwave, IVX Health, ParetoHealth, PartsSource, Passport Health, Qualifacts, Quantum Health, RetireeFirst, RxBenefits, SterilMed and Vatica Health.

This award follows GrowthCap’s recognition of Great Hill for several of its ranking lists, including the Top 25 Growth Equity Firms of 2022 (March 1, 2023) the Top 40 Under 40 Growth Investors of 2022 (December 21, 2022), the Top 25 Software Investors of 2022 (October 25, 2022) and the Top 25 Private Equity Firms of 2022 (September 6, 2022).

Great Hill Partners submitted nominations to be considered for and, once selected, paid to be included on, and to promote inclusion on, all GrowthCap lists noted above.